DiNAQOR Bolsters Leadership with Key Strategic Appointments

DiNAQOR AG, a Swiss health technology group, announced strategic leadership changes enhancing its role as a life science company builder. Dr. Christian Thirion joins as CEO of DiNATEQ AG and Group Chief Strategy & Business Development Officer. He aims to drive corporate strategy and partnerships, building on his previous success at Sirion Biotech.

Simultaneously, Dr. Josef El Andari steps up as Chief Scientific Officer of DiNAQOR AG. With four years at the company, Dr. El Andari has been instrumental in advancing its scientific platforms, notably in genomic medicine and bioengineering.

These appointments highlight DiNAQOR's focus on scaling early-stage drug development and leveraging advanced testing methods, positioning the company for future growth in the biotech sector.